title: Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment.
authors.affiliation: National Cheng Kung University Hospital, College of Medicine, Tainan, Taiwan.
authors.forename: Wei-Pang
authors.initials: WP
authors.lastname: Chung
authors.forename: Hsiang-Lin
authors.initials: HL
authors.lastname: Song
authors.forename: Chung-Liang
authors.initials: CL
authors.lastname: Ho
authors.forename: Nan-Tsing
authors.initials: NT
authors.lastname: Chiu
authors.forename: Wu-Chou
authors.initials: WC
authors.lastname: Su
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D011799:Quinazolines / Q000009:adverse effects*; D012074:Remission Induction; D013275:Stomach Rupture / Q000139:chemically induced* / Q000601:surgery; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib